Literature DB >> 17159110

Proof of genetic heterogeneity in X-linked Charcot-Marie-Tooth disease.

I G Huttner1, M L Kennerson, S W Reddel, D Radovanovic, G A Nicholson.   

Abstract

OBJECTIVE: To characterize a large family with X-linked Charcot-Marie-Tooth (CMT) neuropathy without mutations in the gap junction protein B1 (GJB1) gene, which has an unusual phenotype that is different in some aspects from classic CMTX1.
METHODS: We tested CMT families consistent with X-linked inheritance for GJB1 mutations. We compared the largest family (CMT623) without GJB1 mutation and with linkage excluding the CMTX1 locus to CMTX1 and normal individuals.
RESULTS: Only 51% of probable X-linked CMT families had mutations in GJB1. Family CMT623 shows linkage to Xq26.3-q27.1 (lod score z = 6.58), a region within the previously identified locus for CMTX3, Xq26-q28. Unlike CMTX1, affected males in family CMT623 report pain and paraesthesia before the onset of sensory loss, and women are usually asymptomatic. As in CMTX1, affected males have widely ranging intermediate motor conduction velocities. The coding regions of 14 positional candidate genes within the narrowed CMTX3 locus have been excluded for a pathogenic role in the disease.
CONCLUSION: This study is the first to confirm the CMTX3 locus and to refine the genetic interval to a 5.7-Mb region flanked by the markers DXS1041 and DXS8106. GJB1 mutation-negative forms of X-linked CMT, such as CMTX3, may account for a significant proportion of X-linked CMT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17159110     DOI: 10.1212/01.wnl.0000247271.40782.b7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  X-linked CMT: genes and gene loci in an Australian cohort.

Authors:  Megan Hwa Brewer; Rabia Chaudhry; Keta McDowall; Shannon Chu; Bartosz Kowalski; Patsie Polly; Garth Nicholson; Marina Kennerson
Journal:  Neurogenetics       Date:  2010-03-05       Impact factor: 2.660

Review 2.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

3.  Evidence of a founder haplotype refines the X-linked Charcot-Marie-Tooth (CMTX3) locus to a 2.5 Mb region.

Authors:  Megan Brewer; Febriani Changi; Anthony Antonellis; Kurt Fischbeck; Patsie Polly; Garth Nicholson; Marina Kennerson
Journal:  Neurogenetics       Date:  2008-05-06       Impact factor: 2.660

4.  Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation.

Authors:  Rabia Chaudhry; Aditi Kidambi; Megan Hwa Brewer; Anthony Antonellis; Katherine Mathews; Garth Nicholson; Marina Kennerson
Journal:  Muscle Nerve       Date:  2013-03-29       Impact factor: 3.217

5.  Whole Genome Sequencing Identifies a 78 kb Insertion from Chromosome 8 as the Cause of Charcot-Marie-Tooth Neuropathy CMTX3.

Authors:  Megan H Brewer; Rabia Chaudhry; Jessica Qi; Aditi Kidambi; Alexander P Drew; Manoj P Menezes; Monique M Ryan; Michelle A Farrar; David Mowat; Gopinath M Subramanian; Helen K Young; Stephan Zuchner; Stephen W Reddel; Garth A Nicholson; Marina L Kennerson
Journal:  PLoS Genet       Date:  2016-07-20       Impact factor: 5.917

Review 6.  Structural variations causing inherited peripheral neuropathies: A paradigm for understanding genomic organization, chromatin interactions, and gene dysregulation.

Authors:  Anthony N Cutrupi; Megan H Brewer; Garth A Nicholson; Marina L Kennerson
Journal:  Mol Genet Genomic Med       Date:  2018-03-23       Impact factor: 2.183

Review 7.  Structural Variation at a Disease Mutation Hotspot: Strategies to Investigate Gene Regulation and the 3D Genome.

Authors:  Alexandra Boyling; Gonzalo Perez-Siles; Marina L Kennerson
Journal:  Front Genet       Date:  2022-03-25       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.